The neuroscientific study of hallucinogens
Recently, an important and landmark paper was published in PLoS ONE (hooray open access!) titled, "Investigating the Mechanisms of Hallucinogen-Induced Visions Using 3,4-Methylenedioxyamphetamine (MDA): A Randomized Controlled Trial in Humans". It sounds daunting, but trust me, it's a very cool, approachable study. Now, in the spirit of full-disclosure, the lead author Dr. Matthew Baggott (hereafter referred to as "Matt"), is a friend of mine from grad school and he's been kind enough to grant me a very thorough interview for this post. At the bottom of this post you will also find an hour-long YouTube interview with Matt about his research as part of "Dr. That said, my real-life association with Matt is not biasing my opening statement; his paper is truly landmark for many reasons. [T]here is a staggering diversity of hallucinogens out there: hundreds of compounds, each affecting different combinations of binding sites in the brain. I think you hit the nail on the head.